Ashish Mark Ingle
Ashish Mark Ingle publishes mostly in Molecular Biology, Oncology and Neurology, on topics such as Neuroblastoma Research and Treatments, Glioma Diagnosis and Treatment and Acute Myeloid Leukemia Research.
- World rank
- #269,361 of 7,710,434 ranked researchers
- Rank in United States
- #98,505 of 1,627,098
- Works
- 48
- Citations
- 3.3k
- Citations per work
- 69.3
What does Ashish Mark Ingle research?
Ashish Mark Ingle's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2552.6%
- Medicine2552.6%
- Everything else1226.0%
- Life Sciences1021.4%
- 1Molecular Biology21% of their works
- 2Oncology13% of their works
- 3Neurology12% of their works
- 4Hematology10% of their works
- 5Pulmonary and Respiratory Medicine10% of their works
- 6Genetics8% of their works
Research topics
Which keywords describe Ashish Mark Ingle's research?
The keywords of their largest research topics: Immunotherapy, Prognostic Factors, ALK, Neuroblastoma, Clinical Trials, Targeted Therapy, Glioblastoma and Temozolomide.
- mTOR
- Signaling
- HDAC Inhibitors
- EGFR Mutations
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Temozolomide
- Targeted Therapy
- Neuroblastoma
- Prognostic Factors
- Immunotherapy
- ALK
- Clinical Trials
- Glioblastoma
- AML
- Acute Myeloid Leukemia
- ALK Inhibitors
- Genomic Profiles
- Histone Deacetylases
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Immunotherapy273 topics
- Prognostic Factors173 topics
- ALK131 topic
- Neuroblastoma131 topic
- Clinical Trials102 topics
- Targeted Therapy102 topics
- Glioblastoma91 topic
- Temozolomide91 topic
- AML61 topic
- Acute Lymphoblastic Leukemia61 topic
- Acute Myeloid Leukemia61 topic
- Childhood Cancer61 topic
- ALK Inhibitors51 topic
- EGFR Mutations51 topic
- Genomic Profiles51 topic
- HDAC Inhibitors51 topic
- Histone Deacetylases51 topic
- Signaling51 topic
- Small-Cell Lung Cancer51 topic
- mTOR51 topic
Where does Ashish Mark Ingle work?
Ashish Mark Ingle's main affiliation in the publication record is Children's Oncology Group, United States.
How many publications and citations does Ashish Mark Ingle have?
OpenAlex counts 48 works and 3,326 citations for Ashish Mark Ingle, an h-index of 26, ranking #269,361 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ashish Mark Ingle. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.